Ripa Marco Ricercatore a tempo determinato juniorMedicinaMED/17

Biografia

Pubblicazioni

Biografia

Laurea in Medicina e Chirurgia, Università Vita-Salute San Raffaele, 2012.

 

Specializzazione in Malattie Infettive, Università Vita-Salute San Raffaele, 2018

 

Consulente Infettivologo, Dipartimento Malattie Infettive, Ospedale San Raffaele, 2018

 

Ricercatore in Malattie Infettive (MED/17), 2019

 

ORCID ID: 0000-0002-6380-0377

 

Aree di Ricerca:

  • Endocarditi
  • Infezioni del torrente circolatorio
  • Infezioni nosocomiali
  • Sepsi e shock settico

 

Pubblicazioni

1: Ripa M, Chiappetta S, Castiglioni B, Agricola E, Busnardo E, Carletti S,

Castiglioni A, De Bonis M, La Canna G, Oltolini C, Pajoro U, Pasciuta R, Tassan

Din C, Scarpellini P; Ospedale San Raffaele Endocarditis Team. Impact of

surgical timing on survival in patients with infective endocarditis: a time-

dependent analysis. Eur J Clin Microbiol Infect Dis. 2021 Jan 7. doi:

10.1007/s10096-020-04133-x. Epub ahead of print. PMID: 33411176.

 

2: Oltolini C, Piemontese S, Ripa M, Greco R, Nozza S, Corti C, Peccatori J,

Scarpellini P, Ciceri F, Castagna A. Allogeneic bone marrow transplantation in

HIV people with hematological malignancies: Post-transplant cyclophosphamide to

overcome the HLA-matching barrier. Transpl Infect Dis. 2020 Dec 22:e13551. doi:

10.1111/tid.13551. Epub ahead of print. PMID: 33351984.

 

3: Spagnuolo V, Guffanti M, Galli L, Poli A, Querini PR, Ripa M, Clementi M,

Scarpellini P, Lazzarin A, Tresoldi M, Dagna L, Zangrillo A, Ciceri F, Castagna

A; COVID-BioB study group. Viral clearance after early corticosteroid treatment

in patients with moderate or severe covid-19. Sci Rep. 2020 Dec 4;10(1):21291.

doi: 10.1038/s41598-020-78039-1. PMID: 33277573; PMCID: PMC7718220.

 

4: Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, Muccini C,

Monti G, De Luca G, Landoni G, Dagna L, Clementi M, Rovere Querini P, Ciceri F,

Tresoldi M, Lazzarin A, Zangrillo A, Scarpellini P, Castagna A; COVID-BioB study

group. Secondary infections in patients hospitalized with COVID-19: incidence

and predictive factors. Clin Microbiol Infect. 2020 Oct

24:S1198-743X(20)30652-2. doi: 10.1016/j.cmi.2020.10.021. Epub ahead of print.

PMID: 33223114; PMCID: PMC7584496.

 

5: Mastrangelo A, Germinario BN, Ferrante M, Frangi C, Li Voti R, Muccini C,

Ripa M; COVID-BioB Study Group. Candidemia in COVID-19 patients: incidence and

characteristics in a prospective cohort compared to historical non-COVID-19

controls. Clin Infect Dis. 2020 Oct 30:ciaa1594. doi: 10.1093/cid/ciaa1594. Epub

ahead of print. PMID: 33124650; PMCID: PMC7665423.

 

6: Rovere-Querini P, Tresoldi C, Conte C, Ruggeri A, Ghezzi S, De Lorenzo R, Di

Filippo L, Farina N, Ramirez GA, Ripa M, Mancini N, Cantarelli E, Galli L, Poli

A, De Cobelli F, Bonini C, Manfredi AA, Franchini S, Spessot M, Carlucci M,

Dagna L, Scarpellini P, Ambrosio A, Di Napoli D, Bosi E, Tresoldi M, Lazzarin A,

Landoni G, Martino G, Zangrillo A, Poli G, Castagna A, Vicenzi E, Clementi M,

Ciceri F; COVID-BioB Study Group. Biobanking for COVID-19 research. Panminerva

Med. 2020 Oct 19. doi: 10.23736/S0031-0808.20.04168-3. Epub ahead of print.

PMID: 33073557.

 

7: Natalello G, De Luca G, Gigante L, Campochiaro C, De Lorenzis E, Verardi L,

Paglionico A, Petricca L, Martone AM, Calvisi S, Ripa M, Cavalli G, Della-Torre

E, Tresoldi M, Landi F, Bosello SL, Gremese E, Dagna L. Nailfold capillaroscopy

findings in patients with coronavirus disease 2019: Broadening the spectrum of

COVID-19 microvascular involvement. Microvasc Res. 2021 Jan;133:104071. doi:

10.1016/j.mvr.2020.104071. Epub 2020 Sep 17. PMID: 32949574; PMCID: PMC7494493.

 

8: Oltolini C, Guidetti A, Ripa M, Castiglioni B, Tassan Din C, Mastaglio S,

Canetti D, Monti G, Andolina A, Molinari C, Poloniato A, Mastrangelo A, Ferrante

M, Lanzillotta M, Scarpellini P, Castagna A, Corradini P, Ciceri F. Coronavirus

Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation:

Life-threating Features Within the Early Post-engraftment Phase. Hemasphere.

2020 Aug 10;4(4):e448. doi: 10.1097/HS9.0000000000000448. Erratum in:

Hemasphere. 2020 Sep 16;4(5):e493. PMID: 32885143; PMCID: PMC7430227.

 

9: Della-Torre E, Campochiaro C, Cavalli G, De Luca G, Napolitano A, La Marca S,

Boffini N, Da Prat V, Di Terlizzi G, Lanzillotta M, Rovere Querini P, Ruggeri A,

Landoni G, Tresoldi M, Ciceri F, Zangrillo A, De Cobelli F, Dagna L; SARI-RAF

Study Group; SARI-RAF Study Group members. Interleukin-6 blockade with sarilumab

in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label

cohort study. Ann Rheum Dis. 2020 Oct;79(10):1277-1285. doi:

10.1136/annrheumdis-2020-218122. Epub 2020 Jul 3. PMID: 32620597; PMCID:

PMC7509526.

 

10: Iannaccone S, Castellazzi P, Tettamanti A, Houdayer E, Brugliera L, de

Blasio F, Cimino P, Ripa M, Meloni C, Alemanno F, Scarpellini P. Role of

Rehabilitation Department for Adult Individuals With COVID-19: The Experience of

the San Raffaele Hospital of Milan. Arch Phys Med Rehabil. 2020

Sep;101(9):1656-1661. doi: 10.1016/j.apmr.2020.05.015. Epub 2020 Jun 4. PMID:

32505489; PMCID: PMC7272153.

 

11: Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D,

Oltolini C, Castiglioni B, Tassan Din C, Boffini N, Tomelleri A, Farina N,

Ruggeri A, Rovere-Querini P, Di Lucca G, Martinenghi S, Scotti R, Tresoldi M,

Ciceri F, Landoni G, Zangrillo A, Scarpellini P, Dagna L. Interleukin-1 blockade

with high-dose anakinra in patients with COVID-19, acute respiratory distress

syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol.

2020 Jun;2(6):e325-e331. doi: 10.1016/S2665-9913(20)30127-2. Epub 2020 May 7.

PMID: 32501454; PMCID: PMC7252085.

 

12: Campochiaro C, Della-Torre E, Cavalli G, De Luca G, Ripa M, Boffini N,

Tomelleri A, Baldissera E, Rovere-Querini P, Ruggeri A, Monti G, De Cobelli F,

Zangrillo A, Tresoldi M, Castagna A, Dagna L; TOCI-RAF Study Group. Efficacy and

safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective

cohort study. Eur J Intern Med. 2020 Jun;76:43-49. doi:

10.1016/j.ejim.2020.05.021. Epub 2020 May 22. PMID: 32482597; PMCID: PMC7242960.

 

13: Muscatello A, Nozza S, Fabbiani M, De Benedetto I, Ripa M, Dell'acqua R,

Antinori A, Pinnetti C, Calcagno A, Ferrara M, Focà E, Quiros-Roldan E,

Ripamonti D, Campus M, Maurizio Celesia B, Torti C, Cosco L, Di Biagio A,

Rusconi S, Marchetti G, Mussini C, Gulminetti R, Cingolani A, D'ettorre G,

Madeddu G, Franco A, Orofino G, Squillace N, Gori A, Tambussi G, Bandera A;

Inaction Study Group.. Enhanced Immunological Recovery With Early Start of

Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian

Network of ACuTe HIV InfectiON (INACTION) Retrospective Study. Pathog Immun.

2020 Feb 24;5(1):8-33. doi: 10.20411/pai.v5i1.341. PMID: 32258852; PMCID:

PMC7104556.

 

14: Oltolini C, Greco R, Galli L, Clerici D, Lorentino F, Xue E, Lupo

Stanghellini MT, Giglio F, Uhr L, Ripa M, Scarpellini P, Bernardi M, Corti C,

Peccatori J, Castagna A, Ciceri F. Infections after Allogenic Transplant with

Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching. Biol Blood

Marrow Transplant. 2020 Jun;26(6):1179-1188. doi: 10.1016/j.bbmt.2020.01.013.

Epub 2020 Jan 28. PMID: 32004700.

 

15: Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, Popescu BA,

Prendergast B, Tornos P, Sadeghpour A, Oliver L, Vaskelyte JJ, Sow R, Axler O,

Maggioni AP, Lancellotti P; EURO-ENDO Investigators. Clinical presentation,

aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-

ENDO (European infective endocarditis) registry: a prospective cohort study. Eur

Heart J. 2019 Oct 14;40(39):3222-3232. doi: 10.1093/eurheartj/ehz620. PMID:

31504413.

 

16: Tascini C, Attanasio V, Ripa M, Carozza A, Pallotto C, Bernardo M, Francisci

D, Oltolini C, Palmiero G, Scarpellini P. Ceftobiprole for the treatment of

infective endocarditis: A case series. J Glob Antimicrob Resist. 2020

Mar;20:56-59. doi: 10.1016/j.jgar.2019.07.020. Epub 2019 Jul 24. PMID: 31351247.

 

17: Gianotti N, Muccini C, Galli L, Poli A, Spagnuolo V, Andolina A, Galizzi N,

Ripa M, Messina E, Piatti PM, Lazzarin A, Castagna A. Homeostatic model

assessment for insulin resistance index trajectories in HIV-infected patients

treated with different first-line antiretroviral regimens. J Med Virol. 2019

Nov;91(11):1937-1943. doi: 10.1002/jmv.25541. Epub 2019 Jul 16. PMID: 31286527.

 

18: Habib G, Lancellotti P, Erba PA, Sadeghpour A, Meshaal M, Sambola A, Furnaz

S, Citro R, Ternacle J, Donal E, Cosyns B, Popescu B, Iung B, Prendergast B,

Laroche C, Tornos P, Pazdernik M, Maggioni A, Gale CP; EURO-ENDO Investigators.

The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. Eur Heart J

Qual Care Clin Outcomes. 2019 Jul 1;5(3):202-207. doi: 10.1093/ehjqcco/qcz018.

Erratum in: Eur Heart J Qual Care Clin Outcomes. 2020 Jan 1;6(1):91. PMID:

30957862.

 

19: Ferrari D, Ripa M, Premaschi S, Banfi G, Castagna A, Locatelli M. LC-MS/MS

method for simultaneous determination of linezolid, meropenem, piperacillin and

teicoplanin in human plasma samples. J Pharm Biomed Anal. 2019 May 30;169:11-18.

doi: 10.1016/j.jpba.2019.02.037. Epub 2019 Feb 21. PMID: 30826487.

 

20: Ripa M, Morata L, Rodríguez-Núñez O, Cardozo C, Puerta-Alcalde P, Hernández-

Meneses M, Ambrosioni J, Linares L, Bodro M, Valcárcel A, Casals C, Guerrero-

León MLA, Almela M, Garcia-Vidal C, Del Río A, Marco F, Mensa J, Martínez JA,

Soriano A. Short-Term Peripheral Venous Catheter-Related Bloodstream Infections:

Evidence for Increasing Prevalence of Gram-Negative Microorganisms from a

25-Year Prospective Observational Study. Antimicrob Agents Chemother. 2018 Oct

24;62(11):e00892-18. doi: 10.1128/AAC.00892-18. PMID: 30126952; PMCID:

PMC6201066.

 

21: Oltolini C, Ripa M, Andolina A, Brioschi E, Cilla M, Petrella G, Gregorc V,

Castiglioni B, Tassan Din C, Scarpellini P. Invasive Pulmonary Aspergillosis

Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During

Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and

Review of the Literature. Mycopathologia. 2019 Feb;184(1):181-185. doi:

10.1007/s11046-018-0291-4. Epub 2018 Aug 13. PMID: 30101407.

 

22: Rodríguez-Núñez O, Ripa M, Morata L, de la Calle C, Cardozo C, Fehér C,

Pellicé M, Valcárcel A, Puerta-Alcalde P, Marco F, García-Vidal C, Del Río A,

Soriano A, Martínez-Martínez JA. Evaluation of ceftazidime/avibactam for serious

infections due to multidrug-resistant and extensively drug-resistant Pseudomonas

aeruginosa. J Glob Antimicrob Resist. 2018 Dec;15:136-139. doi:

10.1016/j.jgar.2018.07.010. Epub 2018 Jul 20. PMID: 30036695.

 

23: Gianotti N, Galli L, Galizzi N, Ripa M, Andolina A, Nozza S, Spagnuolo V,

Poli A, Lazzarin A, Castagna A. Time spent with residual viraemia after

virological suppression below 50 HIV-RNA copies/mL according to type of first-

line antiretroviral regimen. Int J Antimicrob Agents. 2018 Oct;52(4):492-499.

doi: 10.1016/j.ijantimicag.2018.07.001. Epub 2018 Sep 13. PMID: 30009958.

 

24: Ramirez GA, Yacoub MR, Ripa M, Mannina D, Cariddi A, Saporiti N, Ciceri F,

Castagna A, Colombo G, Dagna L. Eosinophils from Physiology to Disease: A

Comprehensive Review. Biomed Res Int. 2018 Jan 28;2018:9095275. doi:

10.1155/2018/9095275. PMID: 29619379; PMCID: PMC5829361.

 

25: Ripa M, Rodríguez-Núñez O, Cardozo C, Naharro-Abellán A, Almela M, Marco F,

Morata L, De La Calle C, Del Rio A, Garcia-Vidal C, Ortega MDM, Guerrero-León

MLA, Feher C, Torres B, Puerta-Alcalde P, Mensa J, Soriano A, Martínez JA.

Influence of empirical double-active combination antimicrobial therapy compared

with active monotherapy on mortality in patients with septic shock: a propensity

score-adjusted and matched analysis. J Antimicrob Chemother. 2017 Dec

1;72(12):3443-3452. doi: 10.1093/jac/dkx315. PMID: 28961801.

Il titolare del presente curriculum vitae, pubblicato online sul portale www.unisr.it, è garante in via esclusiva della correttezza e della veridicità dei dati e delle informazioni in esso riportate e del loro eventuale e puntuale aggiornamento. Egli è dunque il diretto ed unico responsabile dei contenuti indicati nei propri curricula.